Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment

Por Brubaker, Kristen D, Brown, Lisha G, Vessella, Robert L, Corey, Eva
Publicado em 2006

Host-derived RANKL is responsible for osteolysis in a C4-2 human prostate cancer xenograft model of experimental bone metastases

Por Morrissey, Colm, Kostenuik, Paul L, Brown, Lisha G, Vessella, Robert L, Corey, Eva
Publicado em 2007

Bone Morphogenetic Protein 7 Is Expressed in Prostate Cancer Metastases and Its Effects on Prostate Tumor Cells Depend on Cell Phenotype and the Tumor Microenvironment

Por Morrissey, Colm, Brown, Lisha G, Pitts, Tiffany EM, Vessella, Robert L, Corey, Eva
Publicado em 2010

Nemo-Like Kinase Induces Apoptosis and Inhibits Androgen Receptor Signaling in Prostate Cancer Cells

Por Emami, Katayoon H., Brown, Lisha G., Pitts, Tiffany E.M., Sun, Xizhang, Vessella, Robert L., Corey, Eva
Publicado em 2009

Inhibition of CCL2 Signaling in Combination with Docetaxel Treatment Has Profound Inhibitory Effects on Prostate Cancer Growth in Bone

Por Kirk, Peter S., Koreckij, Theodore, Nguyen, Holly M., Brown, Lisha G., Snyder, Linda A., Vessella, Robert L., Corey, Eva
Publicado em 2013

Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculature

Por Labrecque, Mark P., Brown, Lisha G., Coleman, Ilsa M., Nguyen, Holly M., Lin, Daniel W., Corey, Eva, Nelson, Peter S., Morrissey, Colm
Publicado no PLoS One (2021)

Inhibition of Androgen-Independent Prostate Cancer by Estrogenic Compounds Is Associated with Increased Expression of Immune-Related Genes

Por Coleman, Ilsa M, Kiefer, Jeffrey A, Brown, Lisha G, Pitts, Tiffany E, Nelson, Peter S, Brubaker, Kristen D, Vessella, Robert L, Corey, Eva
Publicado em 2006

Cabozantinib Inhibits Growth of Androgen-Sensitive and Castration-Resistant Prostate Cancer and Affects Bone Remodeling

Por Nguyen, Holly M., Ruppender, Nazanin, Zhang, Xiaotun, Brown, Lisha G., Gross, Ted S., Morrissey, Colm, Gulati, Roman, Vessella, Robert L., Schimmoller, Frauke, Aftab, Dana T., Corey, Eva
Publicado em 2013

Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment

Por Larson, Sandy R., Chin, Jessica, Zhang, Xiaotun, Brown, Lisha G., Coleman, Ilsa M., Lakely, Bryce, Tenniswood, Martin, Corey, Eva, Nelson, Peter S., Vessella, Robert L., Morrissey, Colm
Publicado em 2013

High-Resolution Genomic Profiling of Disseminated Tumor Cells in Prostate Cancer

Por Wu, Yu, Schoenborn, Jamie R., Morrissey, Colm, Xia, Jing, Larson, Sandy, Brown, Lisha G., Qu, Xiaoyu, Lange, Paul H., Nelson, Peter S., Vessella, Robert L., Fang, Min
Publicado no J Mol Diagn (2016)

The Expression of Osteoclastogenesis-Associated Factors and Osteoblast Response to Osteolytic Prostate Cancer Cells

Por Morrissey, Colm, Lai, Janice S., Brown, Lisha G., Wang, Ya-Chun, Roudier, Martine P., Coleman, Ilsa M., Gulati, Roman, Vakar-Lopez, Funda, True, Lawrence D., Eva, Corey, Nelson, Peter S., Vessella, Robert L.
Publicado em 2010

LuCaP Prostate Cancer Patient‐Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an­­d Serve as Models for Evaluating Cancer Therapeutics

Por Nguyen, Holly M., Vessella, Robert L., Morrissey, Colm, Brown, Lisha G., Coleman, Ilsa M., Higano, Celestia S., Mostaghel, Elahe A., Zhang, Xiaotun, True, Lawrence D., Lam, Hung‐Ming, Roudier, Martine, Lange, Paul H., Nelson, Peter S., Corey, Eva
Publicado no Prostate (2017)

Durable Response of Enzalutamide-resistant Prostate Cancer to Supraphysiological Testosterone Is Associated with a Multifaceted Growth Suppression and Impaired DNA Damage Response...

Por Lam, Hung-Ming, Nguyen, Holly M., Labrecque, Mark P., Brown, Lisha G., Coleman, Ilsa M., Gulati, Roman, Lakely, Bryce, Sondheim, Daniel, Chatterjee, Payel, Marck, Brett T., Matsumoto, Alvin M., Mostaghel, Elahe A., Schweizer, Michael T., Nelson, Peter S., Corey, Eva
Publicado no Eur Urol (2019)

Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived Xenografts

Por Lam, Hung-Ming, McMullin, Ryan, Nguyen, Holly M., Coleman, Ilsa, Gormley, Michael, Gulati, Roman, Brown, Lisha G., Holt, Sarah K., Li, Weimin, Ricci, Deborah S., Verstraeten, Karin, Thomas, Shibu, Mostaghel, Elahe A., Nelson, Peter S., Vessella, Robert L., Corey, Eva
Publicado no Clin Cancer Res (2016)

Identification of Therapeutic Vulnerabilities in Small Cell Neuroendocrine Prostate Cancer

Por Corella, Alexandra N., Ordonio, Ma Victoria Andrea Cabiliza, Coleman, Ilsa, Lucas, Jared M., Kaipainen, Arja, Nguyen, Holly M., Sondheim, Daniel, Brown, Lisha G., True, Lawrence, Lee, John, MacPherson, David, Nghiem, Paul, Gulati, Roman, Morrissey, Colm, Corey, Eva, Nelson, Peter S.
Publicado no Clin Cancer Res (2019)

SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer

Por Zhang, Xiaotun, Coleman, Ilsa M., Brown, Lisha G., True, Lawrence D., Kollath, Lori, Lucas, Jared M., Lam, Hung-Ming, Dumpit, Ruth, Corey, Eva, Chéry, Lisly, Lakely, Bryce, Higano, Celestia S., Montgomery, Bruce, Roudier, Martine, Lange, Paul H., Nelson, Peter S., Vessella, Robert L., Morrissey, Colm
Publicado no Clin Cancer Res (2015)

Epithelial mesenchymal-like transition occurs in a subset of cells in castration resistant prostate cancer bone metastases

Por Haider, Maahum, Zhang, Xiaotun, Coleman, Ilsa, Ericson, Nolan, True, Lawrence D., Lam, Hung-Ming, Brown, Lisha G., Ketchanji, Melanie, Nghiem, Belinda, Lakely, Bryce, Coleman, Roger, Montgomery, Bruce, Lange, Paul H., Roudier, Martine, Higano, Celestia S., Bielas, Jason H., Nelson, Peter S., Vessella, Robert L., Morrissey, Colm
Publicado no Clin Exp Metastasis (2015)

Substantial inter-individual and limited intra-individual genomic diversity among tumors from men with metastatic prostate cancer

Por Kumar, Akash, Coleman, Ilsa, Morrissey, Colm, Zhang, Xiaotun, True, Lawrence D., Gulati, Roman, Etzioni, Ruth, Bolouri, Hamid, Montgomery, Bruce, White, Thomas, Lucas, Jared M., Brown, Lisha G., Dumpit, Ruth F., DeSarkar, Navonil, Higano, Celestia, Yu, Evan Y., Coleman, Roger, Schultz, Nikolaus, Fang, Min, Lange, Paul H., Shendure, Jay, Vessella, Robert L., Nelson, Peter S.
Publicado no Nat Med (2016)

Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer

Por Labrecque, Mark P., Coleman, Ilsa M., Brown, Lisha G., True, Lawrence D., Kollath, Lori, Lakely, Bryce, Nguyen, Holly M., Yang, Yu C., da Costa, Rui M. Gil, Kaipainen, Arja, Coleman, Roger, Higano, Celestia S., Yu, Evan Y., Cheng, Heather H., Mostaghel, Elahe A., Montgomery, Bruce, Schweizer, Michael T., Hsieh, Andrew C., Lin, Daniel W., Corey, Eva, Nelson, Peter S., Morrissey, Colm
Publicado no J Clin Invest (2019)

Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling

Por Bluemn, Eric G., Coleman, Ilsa M., Lucas, Jared M., Coleman, Roger T., Hernandez-Lopez, Susana, Tharakan, Robin, Bianchi-Frias, Daniella, Dumpit, Ruth F., Kaipainen, Arja, Corella, Alexandra N., Yang, Yu Chi, Nyquist, Michael D., Mostaghel, Elahe, Hsieh, Andrew C., Zhang, Xiaotun, Corey, Eva, Brown, Lisha G., Nguyen, Holly M., Pienta, Kenneth, Ittmann, Michael, Schweizer, Michael, True, Lawrence D., Wise, David, Rennie, Paul S., Vessella, Robert L., Morrissey, Colm, Nelson, Peter S.
Publicado no Cancer Cell (2017)